Tag: synthetic biology
-
Anatomy of the “synbio winter” — the tools/DNA-synthesis model survived, the platform/biomanufacturing model foundered, and whether the winter was a science failure or a business-model failure
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All revenues, margins, valuations, layoff rates and bankruptcy facts are attributed to each company’s own reporting (SEC 8-K/10-Q, corporate press releases) or the trade press; company claims, institutional statistics and market estimates are…
-
Biofoundries and the DBTL cycle — automation and AI industrialize the design-build-test-learn loop, but do they close the “design-predictability gap” or just industrialize trial-and-error?
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. Every fold-improvement, titer and throughput figure is attributed to the specific campaign, strain, condition and source; peer-reviewed results, company self-report and marketing are labeled separately (noted inline). Descriptions of listed and defunct companies…
-
Genetic circuits and chassis engineering — where “engineering biology” meets biological reality: Cello’s 92% is a real but bounded demonstration, and the true bottleneck is design predictability, not parts availability
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice, not medical advice. All circuit-accuracy, gene-count, metabolic-burden and generation-count figures are attributed to the specific paper, strain, library and condition in which they were measured; peer-reviewed results are separated from review or secondary…
-
DNA synthesis and genome writing — column chemistry is already cheap and mature; the bottleneck is not the cost of writing DNA, it has moved downstream to design, assembly and context
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All cost, error-rate, length and yield figures are attributed to the platform, kit or publication that reported them; company list prices and vendor performance specs are separated from peer-reviewed and technical-literature values (noted…
Uthando Nethemba 